Umbipro: Opinion on medicine for use outside EU

chlorhexidine

Opinion on medicine for use outside the European Union
Positive opinion

Overview

Umbipro is an antiseptic gel used to prevent infections of the umbilical cord (omphalitis) in newborn babies. Umbipro contains the active substance chlorhexidine.

Opinion details

Product details
Name of medicinal product
Umbipro
Agency opinion number
H-W-3799
Opinion status
Positive opinion
Active substance
chlorhexidine digluconate
International non-proprietary name (INN) or common name
chlorhexidine
Therapeutic area (MeSH)
Soft Tissue Infections
Anatomical therapeutic chemical (ATC) code
D08AC02
Publication details
Opinion holder

GlaxoSmithKline Trading Services
12 Riverwalk
Citywest Business Campus
Dublin 24
Ireland

Date of opinion
28/04/2016

Product information

19/12/2019 Umbipro H-W-3799-IAIN-0005

Contents

Please note that the size of the above document can exceed 50 pages.

You are therefore advised to be selective about which sections or pages you wish to print.

Pharmacotherapeutic group

  • Antiseptics and disinfectants

  • Biguanides and amidines

Therapeutic indication

Umbipro is indicated for prophylaxis of omphalitis (infection of the umbilical cord) in newborn infants.

Assessment history

How useful was this page?

Add your rating